Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells
Authors
Keywords
-
Journal
CARDIOVASCULAR RESEARCH
Volume 112, Issue 3, Pages 677-688
Publisher
Oxford University Press (OUP)
Online
2016-09-23
DOI
10.1093/cvr/cvw209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial HypertensionNovelty and Significance
- (2015) John Granton et al. CIRCULATION RESEARCH
- Intracoronary Stem Cell Infusion After Acute Myocardial Infarction
- (2014) Renate de Jong et al. Circulation-Cardiovascular Interventions
- Cell Therapy in Reperfused Acute Myocardial Infarction Does Not Improve the Recovery of Perfusion in the Infarcted Myocardium: A Cardiac MR Imaging Study
- (2014) Lourens F. H. J. Robbers et al. RADIOLOGY
- Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction
- (2012) Daria Leali et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Infarct Size Determines Myocardial Uptake of CD34 + Cells in the Peri-Infarct Zone
- (2012) Piotr Musialek et al. Circulation-Cardiovascular Imaging
- Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy
- (2011) David M. Leistner et al. Clinical Research in Cardiology
- The Therapeutic Potential of the Humoral Pattern Recognition Molecule PTX3 in Chronic Lung Infection Caused by Pseudomonas aeruginosa
- (2011) F. Moalli et al. JOURNAL OF IMMUNOLOGY
- Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction
- (2011) Junichi Matsubara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
- (2011) D. Leali et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Reinhold Medina et al. MOLECULAR MEDICINE
- Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction
- (2010) Monica Taljaard et al. AMERICAN HEART JOURNAL
- Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities
- (2010) Reinhold J Medina et al. BMC Medical Genomics
- Autologous stem cell therapy for peripheral arterial disease
- (2009) Gian Paolo Fadini et al. ATHEROSCLEROSIS
- Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide
- (2009) Daria Leali et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia
- (2009) Haruki Sekiguchi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dose–Response Relationship of Mesenchymal Stem Cell Transplantation and Functional Regeneration After Severe Skeletal Muscle Injury in Rats
- (2008) Tobias Winkler et al. TISSUE ENGINEERING PART A
- Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
- (2007) Satoshi Suzuki et al. AMERICAN HEART JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now